Legal status by country
Is SHLP2 legal?
Written by Aaron CuhaReviewed Sep 2026
How SHLP2 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule |
| Note | An endogenous mitochondrial-derived peptide. No approved drug acts at CXCR7 for this purpose and no SHLP2 product has been evaluated by the FDA. Material sold under this name is a research chemical. | Endogenous peptide. No licensed product, no registered trial. | Endogenous peptide. Not on the ARTG. | Endogenous peptide. No approved product. |
US FDA status: Not approved, not in development as a drug in any public filing, and with no investigational new drug programme located. It is an endogenous peptide that people can measure in plasma, not a product.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.